New Treatment Strategies for Hepatocellular Carcinoma

New Treatment Strategies for Hepatocellular Carcinoma

Episodes

Specialty:

All

Year:

All

EP. 1: Diagnostic Evaluation of HCC

April 23rd 2018

EP. 2: Methods for Staging HCC

April 23rd 2018

EP. 3: Multidisciplinary Team Approach to Treating HCC

April 23rd 2018

EP. 4: HCC: Criteria for Resection and Adjuvant Therapy

April 23rd 2018

EP. 5: When to Use Locoregional Therapies in HCC

April 23rd 2018

EP. 6: HCC: Role of Radiotherapy and Measuring Response

April 23rd 2018

EP. 7: When to Move to Systemic Therapy in HCC

April 23rd 2018

EP. 8: First-Line Therapy in Advanced HCC

April 23rd 2018

EP. 9: Treatment of Relapsed/Refractory mHCC

April 23rd 2018

EP. 10: Clinical Use of Regorafenib in mHCC

April 23rd 2018

EP. 11: Use of Immunotherapy for HCC

April 23rd 2018

EP. 12: HCC: Emerging Therapies

April 23rd 2018

Trending on OncLive

INBRX-106 Plus Pembrolizumab Improves Responses and PFS in First-Line PD-L1–Positive HNSCC

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

Five Under 5: Top Oncology Videos for the Week of 9/27

AUA Releases Guideline Amendment for NMIBC

Berzosertib Plus Carboplatin Fails to Improve Responses in Pretreated mCRPC